We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Chinese and Western Integrative Medicine for Stage IIIb-IVb Non-Small Cell Lung Cancer: Design and Rationale of a Multicenter, Prospective Registry (NSCLCChinese and Western Integrative Medicine cohort).
- Authors
Lin, Jietao; Sun, Lingling; Chen, Hanrui; Chen, Wenmin; Zhang, Zexin; Cao, Yang; Lin, Lizhu
- Abstract
Introduction: This planned multicenter observational study will evaluate the overall survival of those undergoing integrated Chinese and Western medicine for stage IIIb-IVb non-small cell lung cancer and analyze the factors related to the prognosis. Method and Analysis: The prospective cohort will enroll patients with stage IIIb-IVb NSCLC from March 1, 2019, to December 31, 2025, and follow them for 5 years. We plan to collect data on the patients' demographics, treatment, overall survival, and factors related to the prognosis. Ethics and Dissemination: The institutional review board and ethics committee reviewed the study protocol. All patients will provide informed consent before enrollment.
- Subjects
MEDICINE; LUNG cancer; RESEARCH; SCIENTIFIC observation; INTEGRATIVE medicine; TUMOR classification; CHINESE medicine; LONGITUDINAL method
- Publication
Integrative Cancer Therapies, 2023, Vol 22, p1
- ISSN
1534-7354
- Publication type
Article
- DOI
10.1177/15347354231185109